These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 12838187)

  • 1. Corticosteroids in the initial treatment of Kawasaki disease: report of a randomized trial.
    Sundel RP; Baker AL; Fulton DR; Newburger JW
    J Pediatr; 2003 Jun; 142(6):611-6. PubMed ID: 12838187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease.
    Furukawa T; Kishiro M; Akimoto K; Nagata S; Shimizu T; Yamashiro Y
    Arch Dis Child; 2008 Feb; 93(2):142-6. PubMed ID: 17962370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease.
    Tse SM; Silverman ED; McCrindle BW; Yeung RS
    J Pediatr; 2002 Apr; 140(4):450-5. PubMed ID: 12006960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited.
    Hsieh KS; Weng KP; Lin CC; Huang TC; Lee CL; Huang SM
    Pediatrics; 2004 Dec; 114(6):e689-93. PubMed ID: 15545617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose methotrexate therapy for intravenous immunoglobulin-resistant Kawasaki disease.
    Lee TJ; Kim KH; Chun JK; Kim DS
    Yonsei Med J; 2008 Oct; 49(5):714-8. PubMed ID: 18972590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corticosteroid treatment of refractory Kawasaki disease.
    Lang BA; Yeung RS; Oen KG; Malleson PN; Huber AM; Riley M; Ebbeson R; Ramsey SE; Laxer RM; Silverman ED; McCrindle BW; Ratnapalan S; Feldman BM
    J Rheumatol; 2006 Apr; 33(4):803-9. PubMed ID: 16583481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Methylprednisolone pulse therapy in Kawasaki disease].
    Miura M; Matsuoka M; Kohno K; Ohki H; Yoshiba S
    Nihon Rinsho; 2008 Feb; 66(2):338-42. PubMed ID: 18265457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous immunoglobulin preparation type: association with outcomes for patients with acute Kawasaki disease.
    Manlhiot C; Yeung RS; Chahal N; McCrindle BW
    Pediatr Allergy Immunol; 2010 May; 21(3):515-21. PubMed ID: 20546528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Kawasaki disease with a moderate dose (1 g/kg) of intravenous immunoglobulin.
    Khowsathit P; Hong-Hgam C; Khositseth A; Wanitkun S
    J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1121-6. PubMed ID: 12549785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial.
    Tremoulet AH; Jain S; Jaggi P; Jimenez-Fernandez S; Pancheri JM; Sun X; Kanegaye JT; Kovalchin JP; Printz BF; Ramilo O; Burns JC
    Lancet; 2014 May; 383(9930):1731-8. PubMed ID: 24572997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of initial corticosteroid therapy on coronary artery aneurysm formation in Kawasaki disease: a meta-analysis of 862 children.
    Wooditch AC; Aronoff SC
    Pediatrics; 2005 Oct; 116(4):989-95. PubMed ID: 16199713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Steroid pulse therapy].
    Miura M
    Nihon Rinsho; 2014 Sep; 72(9):1631-5. PubMed ID: 25518414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of three intravenous gamma globulin regimens on Kawasaki disease and relevant coronary complication rates in pediatric patients: a comparative study].
    DU ZD; Zhao D; DU JB; Lu S; Yi JM; Hou AC; Zhou ZS; Ding GF;
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(44):3119-21. PubMed ID: 18269869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease.
    Egami K; Muta H; Ishii M; Suda K; Sugahara Y; Iemura M; Matsuishi T
    J Pediatr; 2006 Aug; 149(2):237-40. PubMed ID: 16887442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of potential risk factors associated with nonresponse to initial intravenous immunoglobulin treatment among Kawasaki disease patients in Japan.
    Uehara R; Belay ED; Maddox RA; Holman RC; Nakamura Y; Yashiro M; Oki I; Ogino H; Schonberger LB; Yanagawa H
    Pediatr Infect Dis J; 2008 Feb; 27(2):155-60. PubMed ID: 18174868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment.
    Durongpisitkul K; Gururaj VJ; Park JM; Martin CF
    Pediatrics; 1995 Dec; 96(6):1057-61. PubMed ID: 7491221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy and safety of glucocorticoids in addition to intravenous immunoglobulin in the initial treatment of Kawasaki disease: a meta-analysis of randomized trials].
    Hu JW; Zhou ZS; Yang L; Zheng CN; Wang KD
    Zhonghua Yi Xue Za Zhi; 2011 May; 91(18):1259-64. PubMed ID: 21756798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical responses of patients with Kawasaki disease to different brands of intravenous immunoglobulin.
    Tsai MH; Huang YC; Yen MH; Li CC; Chiu CH; Lin PY; Lin TY; Chang LY
    J Pediatr; 2006 Jan; 148(1):38-43. PubMed ID: 16423595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management and outcome of intravenous gammaglobulin-resistant Kawasaki disease.
    Sittiwangkul R; Pongprot Y; Silvilairat S; Phornphutkul C
    Singapore Med J; 2006 Sep; 47(9):780-4. PubMed ID: 16924360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corticosteroid pulse combination therapy for refractory Kawasaki disease: a randomized trial.
    Ogata S; Ogihara Y; Honda T; Kon S; Akiyama K; Ishii M
    Pediatrics; 2012 Jan; 129(1):e17-23. PubMed ID: 22144699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.